Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Inspire Medical Systems Announces Preliminary Q2 Revenue Of $195.9M Vs $186.3M Est

Author: Benzinga Newsdesk | July 29, 2024 06:47am

Preliminary, Unaudited Second Quarter Revenue

Revenue for the second quarter is anticipated to be $195.9 million, a 30% increase over the same quarter of 2023
- U.S. revenue is expected to be $187.8 million, a 30% increase over the same quarter of 2023
- Revenue outside of the U.S. is expected to be $8.1 million, a 27% increase over the same quarter of 2023

Posted In: INSP